SCREEN for Type 1 Diabetes Act of 2024
Latest Action
Referred to the House Committee on Energy and Commerce.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The SCREEN for Type 1 Diabetes Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing Type 1 diabetes through screening initiatives. The bill was referred to the House Committee on Energy and Commerce but did not advance further and is currently classified as failed or expired. No official summary or full text is publicly available to provide detailed provisions or mechanisms of the bill.
This bill sought to promote screening for Type 1 diabetes but did not progress beyond committee referral and ultimately expired without enactment.
- The bill focuses on Type 1 diabetes screening, indicating a health policy area.
- It was introduced in the House and referred to the House Committee on Energy and Commerce.
- The bill failed to advance and is currently expired with no further legislative action recorded.
['Individuals at risk for or living with Type 1 diabetes', 'Healthcare providers involved in diabetes care and screening', 'Public health agencies focused on chronic disease prevention and management']
['Lack of publicly available full text limits understanding of implementation details and funding mechanisms', 'No information on oversight or enforcement provisions is available', 'Potential costs and resource allocation for screening programs are unknown']
The bill was introduced during the 118th Congress and referred to a relevant committee but did not proceed further. The absence of additional legislative activity suggests limited congressional movement on this specific proposal during the session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased early detection of Type 1 diabetes if screening programs were implemented', 'Possible shifts in healthcare resource allocation toward diabetes screening and management', 'Enhanced public health data collection on Type 1 diabetes prevalence and risk factors']
The absence of an official summary and full bill text limits transparency and public understanding of the bill's scope and provisions. This lack of information also restricts oversight capabilities and informed policy debate. Tracking future similar proposals with more complete documentation would improve transparency and accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.